<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30275854</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>04</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Print">1738-6756</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>21</Volume>                    <Issue>3</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>Journal of breast cancer</Title>                <ISOAbbreviation>J Breast Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>Hypoxia-Inducible Factor 1α Regulates the Transforming Growth Factor β1/SMAD Family Member 3 Pathway to Promote Breast Cancer Progression.</ArticleTitle>            <Pagination>                <MedlinePgn>259-266</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.4048/jbc.2018.21.e42</ELocationID>            <Abstract>                <AbstractText Label="Purpose" NlmCategory="UNASSIGNED">The transforming growth factor β1 (TGF-β1)/SMAD family member 3 (SMAD3) pathway, and hypoxia-inducible factor 1α (HIF-1α) are two key players in various types of malignancies including breast cancer. The TGF-β1/SMAD3 pathway can interact with HIF-1α in some diseases; however, their interaction in breast cancer is still unknown. Therefore, our study aimed to investigate the interactions between the TGF-β1/SMAD3 pathway and HIF-1α in breast cancer.</AbstractText>                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">Expression of HIF-1α in serum of breast cancer patients and healthy controls was detected by quantitative reverse transcription polymerase chain reaction, and the diagnostic value of HIF-1α for breast cancer was evaluated by receiver operating characteristic curve analysis. Breast cancer cell lines overexpressing SMAD3 and HIF-1α were established. Cell apoptosis and proliferation following different treatments were detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, and cell counting kit-8, respectively. Expression of related proteins was detected by western blot.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Serum levels of HIF-1α were higher in breast cancer patients than in normal controls. Both SMAD3 and HIF-1α overexpression inhibited cell apoptosis and promoted cell proliferation. Treatment with inhibitors of HIF-1α and SMAD3 promoted apoptosis in breast cancer cells and inhibited their proliferation. Overexpression of HIF-1α promoted the expression of TGF-β1 and SMAD3, while SMAD3 overexpression did not significantly affect expression of HIF-1α or TGF-β1.</AbstractText>                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">HIF-1α serves as an upstream regulator of the TGF-β1/SMAD3 pathway and promotes the growth of breast cancer.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Peng</LastName>                    <ForeName>Jianheng</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Physical Examination, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wang</LastName>                    <ForeName>Xiaolin</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Physical Examination, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ran</LastName>                    <ForeName>Liang</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Physical Examination, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Song</LastName>                    <ForeName>Junlong</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Luo</LastName>                    <ForeName>Rong</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Physical Examination, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wang</LastName>                    <ForeName>Yonghong</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Physical Examination, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>20</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Korea (South)</Country>            <MedlineTA>J Breast Cancer</MedlineTA>            <NlmUniqueID>101314183</NlmUniqueID>            <ISSNLinking>1738-6756</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Oncol. 2015 Apr;46(4):1730-8</RefSource>                <PMID Version="1">25647396</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2015 Feb 06;10(2):e0117440</RefSource>                <PMID Version="1">25659153</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Nephrol. 2016;44(4):276-285</RefSource>                <PMID Version="1">27607351</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2000 Sep 1;60(17):4693-6</RefSource>                <PMID Version="1">10987269</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Rep. 2014 Oct 9;9(1):349-365</RefSource>                <PMID Version="1">25263561</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2015 Nov-Dec;65(6):481-95</RefSource>                <PMID Version="1">26431342</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2015 May 20;6(14):11768-78</RefSource>                <PMID Version="1">26059435</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Chin Med Sci J. 2011 Sep;26(3):158-62</RefSource>                <PMID Version="1">22207924</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lung Cancer. 2005 Sep;49(3):325-35</RefSource>                <PMID Version="1">15935515</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2003 Oct;3(10):721-32</RefSource>                <PMID Version="1">13130303</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2009 Dec 15;15(24):7471-7478</RefSource>                <PMID Version="1">20008847</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asia Pac J Clin Nutr. 2014;23(1):174-80</RefSource>                <PMID Version="1">24561986</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Prostate. 2014 May;74(5):528-36</RefSource>                <PMID Version="1">24435707</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2016 Jan 13;11(1):e0146823</RefSource>                <PMID Version="1">26760782</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2000 Dec 15;60(24):7106-13</RefSource>                <PMID Version="1">11156418</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2017 Jan;17(1):54-64</RefSource>                <PMID Version="1">27885264</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2014 Jun 13;9(6):e99835</RefSource>                <PMID Version="1">24927122</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomarkers. 2008 Nov;13(7):680-91</RefSource>                <PMID Version="1">19096962</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2015 May-Jun;65(3):221-38</RefSource>                <PMID Version="1">25960198</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2017 Nov;67(6):439-448</RefSource>                <PMID Version="1">28972651</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Cancer Drug Targets. 2006 Aug;6(5):365-84</RefSource>                <PMID Version="1">16918307</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast neoplasms</Keyword>            <Keyword MajorTopicYN="N">Hypoxia-inducible factor 1</Keyword>            <Keyword MajorTopicYN="N">Smad3 protein</Keyword>            <Keyword MajorTopicYN="N">Transforming growth factor beta1</Keyword>        </KeywordList>        <CoiStatement>CONFLICT OF INTEREST: The authors declare that they have no competing interests.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>03</Month>                <Day>31</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>06</Month>                <Day>28</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30275854</ArticleId>            <ArticleId IdType="doi">10.4048/jbc.2018.21.e42</ArticleId>            <ArticleId IdType="pmc">PMC6158164</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>